Clinical Trials in Pittsburgh

Showing 6481-6500 of 21,047 trials

Sedentary Behavior Reduction in Pregnancy Intervention Study

NCT05093842

This pilot and feasibility study will enroll newly pregnant women at risk for high sedentary behavior (SED) and elevated APO risk (n=53) and will randomize them to either a SED reduction intervention or control. Research aims include to: 1) demonstrate our ability to decrease SED and increase standing and light activity in pregnant women; 2) evaluate feasibility; and 3) gather preliminary effects on clinical outcomes including APOs, cardiometabolic risk factors, well-being, and fetal outcomes.

Pregnancy ComplicationsSedentary Behavior

University of Pittsburgh51 participantsStarted Oct 2021

Pittsburgh, Pennsylvania, United States

COMPLETED< 1 mile

An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MI

NCT04717492

The study is a prospective, observational study of patients admitted to the BLOCK COPD network hospitals with acute AMI and Chronic Obstructive Pulmonary Disease (COPD) to determine the prevalence of COPD in patients admitted to the hospital with an acute myocardial infarction (AMI) and to characterize the phenotypic expression and severity of their underlying lung disease. Patients with will be identified via the EMR. 571 participants will be enrolled.

Pulmonary Disease, Chronic Obstructive

University of Minnesota584 participantsStarted Jun 2020

Birmingham, Alabama, United States • Fresno, California, United States • Los Angeles, California, United States +21 more locations

Sedentary Behavior Reduction in Pregnancy Intervention Study

An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MI

Find Trials by Condition in Pittsburgh

Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)

Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies

Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in People With T2 Diabetes

Coordinated, Collaborative, Comprehensive, Family-based, Integrated, Technology-enabled Stroke Care

A Study of Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL)

Phase 1, Open-label, Single Dose Study to Examine Safety, Tolerability, Pharmacokinetics and Virologic Impact of VRC01LS or VRC07-523LS in HIV-infected Viremic Adults

Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction

The INSPIRE-ASP PNA Trial

HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy

A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers

Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer

Bright Ideas - CIN Feasibility Study

Plasma Resuscitation Without Lung Injury

Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium

Avelumab in First-line NSCLC (JAVELIN Lung 100)

D-CARE - The Dementia Care Study: A Pragmatic Clinical Trial of Health System-Based Versus Community-Based Dementia Care

Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood

PMCF Study on the Safety, Performance and Clinical Benefits Data of the ToggleLoc™ 2.9mm in the Elbow